resources

Jubilant Pharmova Ltd.

NSE: JUBLPHARMA

BSE: 530019

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

997.75+47.4 (+4.99%)

8 Sep, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Jubilant Pharmova Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	28May 2Jun 2Aug 8Aug 31Oct	3Feb 9Feb	—	—	—
Presentations	—	—	—	—	—	—	—	—	18Jun	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Jubilant Pharmova Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

General1 Sept 2026
Receipt Of Show Cause Notice By Jubilant Pharmova Limited - GST
Receipt of Show Cause Notice by Jubilant Pharmova Limited - GST
Newspaper Publication29 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Relodgement and KYC Updation
General28 Aug 2026
Receipt Of Show Cause Notice - Jubilant Generics Limited
Receipt of Show Cause Notice - Jubilant Generics Limited
AGM26 Aug 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s Report
AGM26 Aug 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of AGM
General23 Aug 2026
USFDA Approval For Line 3, Contract Manufacturing Facility, Spokane, U.S.A
USFDA Approval for Line 3, Contract manufacturing facility, Spokane, USA
Postal Ballot17 Aug 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Outcome of Postal Ballot
Postal Ballot17 Aug 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer''s Report
Newspaper Publication11 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publications
Press Release / Media Release10 Aug 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release and presentation
Outcome of Board Meeting10 Aug 2026
Board Meeting Outcome for Meeting Held On August 10, 2026
outcome of Board meeting
Analyst / Investor Meet5 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors/ Analysts Meeting
Board Meeting Rescheduled5 Aug 2026
Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting Scheduled For August 10, 2026
Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....
General2 Aug 2026
Newspaper Advertisements Titled ''Notice Of 48Th Annual General Meeting, E-Voting, Record Date And Final Dividend Information
Newspaper advertisements titled ''Notice of 48th Annual General Meeting, E-voting, Record Date and Final Dividend Information''
General1 Aug 2026
Intimation To Shareholders About Deduction Of Tax At Source (TDS) On Final Dividend For FY 2025-26, If Approved By The Members At The Ensuing AGM
Intimation to shareholders about deduction of tax at source (TDS) on Final Dividend for FY 2026-26, if approved by the members at the ensuing AGM
General1 Aug 2026
Intimation Regarding Letter Dispatched To The Shareholders Whose Email Ids Are Not Registered, For AGM Notice, TDS Communication And Annual Report Of The Company For FY 2025-26
Intimation regarding letter dispatched to the shareholders whose email IDs are not registered, for AGM Notice, TDS Communication and Annual Report of the Company for FY 2025-26
Business Responsibility and Sustainability Reporting (BRSR)1 Aug 2026
Business Responsibility and Sustainability Reporting (BRSR)
Please find enclosed herewith the Business Responsibility and Sustainability Report for the financial year 2025-26
AGM1 Aug 2026
Please Find Attached Herewith The Notice Of 48Th Annual General Meeting Alongwith The Annual Report For The Financial Year 2025-26. The 48Th AGM Of The Company Will Be Held On Wednesday, August 26, 2026 Through Video Conferencing / Other Audio Visual Means.
Please find attached herewith the Notice of 48th Annual General Meeting alongwith the Annual Report for the Financial Year 2025-26. The 48th AGM of the Company will be held on Wednesday, ....
Reg. 34 (1) Annual Report1 Aug 2026
Reg. 34 (1) Annual Report.
Pursuant to Regulations 30 & 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Annual Report along with Notice of AGM ....
Reg. 34 (1) Annual Report1 Aug 2026
Reg. 34 (1) Annual Report.
Pursuant to Regulations 30 & 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Annual Report along with Notice of AGM ....

Frequently Asked Questions

Where can I download the annual report of Jubilant Pharmova Ltd.?

Annual reports of Jubilant Pharmova Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Jubilant Pharmova Ltd.?

Quarterly earnings results and presentations of Jubilant Pharmova Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Jubilant Pharmova Ltd. publish earnings call transcripts?

Earnings call transcripts of Jubilant Pharmova Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Jubilant Pharmova Ltd.?

Investor presentations and annual day presentations of Jubilant Pharmova Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Jubilant Pharmova Ltd.?

Corporate announcements and regulatory filings of Jubilant Pharmova Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Jubilant Pharmova Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Jubilant Pharmova Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Jubilant Pharmova Ltd.?

The ISIN (International Securities Identification Number) of Jubilant Pharmova Ltd. is INE700A01033. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Jubilant Pharmova Ltd. listed?

Jubilant Pharmova Ltd. is listed on NSE and BSE. The NSE symbol is JUBLPHARMA and the BSE code is -.

Where can I find the shareholding pattern of Jubilant Pharmova Ltd.?

The quarterly shareholding pattern of Jubilant Pharmova Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Jubilant Pharmova Ltd. on Sharpely?

Share price data for Jubilant Pharmova Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.